Principal Financial Group’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-20,598
| Closed | -$2M | – | 2322 |
|
|
2019
Q3 | $2M | Sell |
20,598
-12,203
| -37% | -$1.22M | ﹤0.01% | 1722 |
|
|
2019
Q2 | $3.36M | Sell |
32,801
-25,286
| -44% | -$2.73M | ﹤0.01% | 1633 |
|
|
2019
Q1 | $6.62M | Buy |
58,087
+3,995
| +7% | +$294K | 0.01% | 1445 |
|
|
2018
Q4 | $2.12M | Sell |
54,092
-6,410
| -11% | -$278K | ﹤0.01% | 1709 |
|
|
2018
Q3 | $3.3M | Sell |
60,502
-1,588
| -3% | -$109K | ﹤0.01% | 1694 |
|
|
2018
Q2 | $5.14M | Buy |
62,090
+123
| +0.2% | +$9.49K | ﹤0.01% | 1589 |
|
|
2018
Q1 | $4.13M | Sell |
61,967
-194
| -0.3% | -$11.2K | ﹤0.01% | 1614 |
|
|
2017
Q4 | $3.2M | Buy |
62,161
+8,073
| +15% | +$580K | ﹤0.01% | 1683 |
|
|
2017
Q3 | $4.82M | Buy |
54,088
+10,399
| +24% | +$790K | ﹤0.01% | 1569 |
|
|
2017
Q2 | $2.61M | Buy |
43,689
+4,937
| +13% | +$276K | ﹤0.01% | 1719 |
|
|
2017
Q1 | $2.07M | Buy |
38,752
+122
| +0.3% | +$7.24K | ﹤0.01% | 1723 |
|
|
2016
Q4 | $1.93M | Buy |
38,630
+5,860
| +18% | +$314K | ﹤0.01% | 1723 |
|
|
2016
Q3 | $1.97M | Buy |
32,770
+13,250
| +68% | +$764K | ﹤0.01% | 1680 |
|
|
2016
Q2 | $998K | Sell |
19,520
-170
| -0.9% | -$7.26K | ﹤0.01% | 1752 |
|
|
2016
Q1 | $581K | Sell |
19,690
-240
| -1% | -$7.57K | ﹤0.01% | 1806 |
|
|
2015
Q4 | $903K | Buy |
19,930
+43
| +0.2% | +$2.25K | ﹤0.01% | 1777 |
|
|
2015
Q3 | $830K | Buy |
19,887
+370
| +2% | +$19.3K | ﹤0.01% | 1797 |
|
|
2015
Q2 | $1.18M | Buy |
19,517
+1,517
| +8% | +$100K | ﹤0.01% | 1764 |
|
|
2015
Q1 | $1.39M | Buy |
+18,000
| New | +$1.04M | ﹤0.01% | 1715 |
|
Principal Financial Group's ONCE Position: Q4 2019 in Review
Principal Financial Group sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 20,598 shares — an estimated $2M sold.
Principal Financial Group first reported a position in ONCE in Q1 2015 and held it in 19 quarters. The position peaked at $6.62M in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.
- Principal Financial Group reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
- Principal Financial Group sold 20,598 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $2M.
- Principal Financial Group first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 19 quarters.
- Principal Financial Group's Spark Therapeutics, Inc. Common Stock position peaked at $6.62M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.
Based on Principal Financial Group's 13F filing for Q4 2019, filed 5 Feb 2020.